These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

623 related articles for article (PubMed ID: 28105733)

  • 21. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Wang WC
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD003146. PubMed ID: 28094851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Estcourt LJ; Kohli R; Hopewell S; Trivella M; Wang WC
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003146. PubMed ID: 32716555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled nitric oxide for treating pain crises in people with sickle cell disease.
    Aboursheid T; Albaroudi O; Alahdab F
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD011808. PubMed ID: 31603241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D for the management of chronic obstructive pulmonary disease.
    Williamson A; Martineau AR; Jolliffe D; Sheikh A; Janssens W; Sluyter J; Rafiq R; de Jongh R; Griffiths CJ
    Cochrane Database Syst Rev; 2024 Sep; 9(9):CD013284. PubMed ID: 39329240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease.
    van Zuuren EJ; Fedorowicz Z
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010155. PubMed ID: 26684281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease.
    Pal S; Dixit R; Moe S; Godinho MA; Abas AB; Ballas SK; Ram S; Yousuf UAM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012762. PubMed ID: 32124977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventions for chronic kidney disease in people with sickle cell disease.
    Roy NB; Carpenter A; Dale-Harris I; Dorée C; Estcourt LJ
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012380. PubMed ID: 37539955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D for the management of asthma.
    Williamson A; Martineau AR; Sheikh A; Jolliffe D; Griffiths CJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD011511. PubMed ID: 36744416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin A and beta (β)-carotene supplementation for cystic fibrosis.
    de Vries JJ; Chang AB; Bonifant CM; Shevill E; Marchant JM
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006751. PubMed ID: 30091146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioxidant supplementation for lung disease in cystic fibrosis.
    Ciofu O; Smith S; Lykkesfeldt J
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD007020. PubMed ID: 31580490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interventions for chronic kidney disease in people with sickle cell disease.
    Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral vitamin D supplementation for adults with obesity undergoing bariatric surgery.
    Chakhtoura MT; Nakhoul NF; Akl EA; Safadi BY; Mantzoros CS; Metzendorf MI; El-Hajj Fuleihan G
    Cochrane Database Syst Rev; 2024 Oct; 10(10):CD011800. PubMed ID: 39351881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-3 fatty acid supplementation for cystic fibrosis.
    Watson H; Stackhouse C
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutritional interventions for survivors of childhood cancer.
    Cohen JE; Wakefield CE; Cohn RJ
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD009678. PubMed ID: 27545902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment for osteoporosis in people with ß-thalassaemia.
    Bhardwaj A; Swe KM; Sinha NK; Osunkwo I
    Cochrane Database Syst Rev; 2016 Mar; 3():CD010429. PubMed ID: 26964506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment for osteoporosis in people with beta-thalassaemia.
    Bhardwaj A; Swe KMM; Sinha NK
    Cochrane Database Syst Rev; 2023 May; 5(5):CD010429. PubMed ID: 37159055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium and vitamin D for increasing bone mineral density in premenopausal women.
    Méndez-Sánchez L; Clark P; Winzenberg TM; Tugwell P; Correa-Burrows P; Costello R
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012664. PubMed ID: 36705288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D supplementation for women during pregnancy.
    De-Regil LM; Palacios C; Lombardo LK; Peña-Rosas JP
    Cochrane Database Syst Rev; 2016 Jan; (1):CD008873. PubMed ID: 26765344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisphosphonates for osteoporosis in people with cystic fibrosis.
    Jeffery TC; Chang AB; Conwell LS
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD002010. PubMed ID: 36625789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.